Back

The predictive value of CHA2DS2-VASc score on adverse in-hospital outcomes among patients with the acute coronary syndrome and atrial fibrillation who undergo PCI

31 August 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Epidemiology, Prognosis, Outcome in Acute Coronary Syndromes – New Insights Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Josip Andjelo Borovac

University Hospital Centre Split, Split (Croatia)

8 More presentations in this session

Presentation thumbnail
The association between osteoarthritis and invasive treatment and clinical outcomes in 6.5 million patients presenting with acute myocardial infarction.
Mr S. Parmar (London, GB)
Abstract Slides Video
Presentation thumbnail
Temporal trends in treatment and outcomes of patients with acute coronary syndrome and concomitant moderate to severe renal failure
Doctor M. Bossard (Lucerne, CH)
Abstract Slides Video
Presentation thumbnail
Angiopoietin-2 is a long-term predictor of all-cause mortality, cardiac death and sudden cardiac death in chest-pain patients with suspected acute coronary syndrome.
Doctor R. Aarsetoey (Stavanger, NO)
Abstract Slides Video
Presentation thumbnail
Real-world evidence on short- and long-term outcomes for acute coronary syndrome patients with a prior history of atrial fibrillation
Doctor P. Gouda (Edmonton, CA)
Abstract Slides Video
Presentation thumbnail
Spontaneous coronary artery dissection - contemporary management and outcome of a national cohort
Mr H. Wilander (Linkoping, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology, Prognosis, Outcome in Acute Coronary Syndromes – New Insights

The Event

Event poster

ESC Congress 2020

31 August 2020 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources